For some patients with specific medical conditions like epilepsy or multiple sclerosis, who are resistant to conventional treatment, the NHS path may be better. However, for most people, private practice remains a better option for getting a prescription for medical cannabis.
Patients often face a choice between the NHS and private clinics. Both routes offer pathways, but the experience, cost, and chances of success are very different.
NHS Access Is Rare
The NHS doctors can prescribe cannabis-based medicines, but only in very limited cases. At present, prescriptions are mainly restricted to three conditions: treatment-resistant epilepsy, multiple sclerosis (MS) spasticity, and chemotherapy-induced nausea and vomiting.
Even then, access is narrow. The NHS has only funded a small number of prescriptions since the law changed. For most patients with chronic pain, anxiety, or other conditions, the NHS route is effectively closed.
Why NHS Access Is So Limited
The main barrier is evidence. The NHS relies on strong clinical trial data before approving medicines for wide use.
While there is promising research on medical cannabis, many studies are still considered too small or inconsistent to meet the NHS standard.
Cost also plays a role. The NHS must balance budgets, and without firm evidence, decision makers are cautious about funding cannabis-based medicines.
What The Private Route Looks Like
Private clinics began opening soon after the law changed. They provide another path for patients who cannot access treatment through the NHS. These clinics employ doctors registered with the General Medical Council who specialise in prescribing cannabis-based medicines. Conditions treated privately go beyond the NHS list. Chronic pain, anxiety, post-traumatic stress disorder (PTSD), and sleep disorders are among the common reasons patients seek help.
The process is fairly direct. Patients must submit their medical records to show they have tried conventional treatments without success. If approved, a prescription may be issued for oils, capsules, or sprays. Consultations take place in person or online, with follow-ups scheduled to monitor progress.
The Cost of Private Care
The biggest difference between NHS and private care is cost. NHS prescriptions are covered as part of normal treatment, but private prescriptions are not. Patients must pay for consultations as well as the medicine itself. Initial appointments often cost between £100 and £200, with follow-ups around £50 to £100. The medicines add another several hundred pounds each month. For some families, this quickly becomes a heavy financial burden.
What Patients Can Expect from Each Route
Those who manage to secure an NHS prescription benefit from stable access at little to no personal cost. However, very few succeed, as most conditions do not qualify.
Private clinics are more open and responsive, but patients pay the full price. Waiting times also differ. NHS pathways can involve long delays and multiple layers of approval, while private clinics can arrange an assessment within weeks.
Perceptions And Trust
Another factor patients weigh is trust. The NHS is seen as cautious and conservative, which reassures some patients but frustrates others.
Private clinics are quicker to prescribe medical cannabis, which offers relief to people in pain, but critics argue that commercial interests may sometimes outweigh caution. Patients must decide which balance feels right for them.
In time, more clinical trials may strengthen the case for NHS use. If new evidence shows clear benefits and cost-effectiveness, wider NHS prescribing could follow. For now, most patients turn to private clinics when conventional treatments fail.
Choosing The Right Path
The choice between NHS and private care depends on personal circumstances. Patients with one of the few NHS-approved conditions should try the NHS route first.
However, others, particularly those with chronic pain or mental health needs, often find that private clinics are the only realistic option. The decision also comes down to cost. For those who can afford it, private care offers faster and broader access. For others, the high price remains out of reach.
Final Thoughts
Medical cannabis in the UK sits at the boundary of law, medicine, and patient need. The NHS offers security but little availability. Private clinics provide choice but at a cost. For now, each patient must weigh the limits of NHS care against the expense of private treatment. The best route is often determined less by medical need and more by what is possible under today’s rules.
